Page last updated: 2024-11-04

sulfadiazine and Syncope

sulfadiazine has been researched along with Syncope in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Syncope: A transient loss of consciousness and postural tone caused by diminished blood flow to the brain (i.e., BRAIN ISCHEMIA). Presyncope refers to the sensation of lightheadedness and loss of strength that precedes a syncopal event or accompanies an incomplete syncope. (From Adams et al., Principles of Neurology, 6th ed, pp367-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mary, AS1
Hamilton, M1

Other Studies

1 other study available for sulfadiazine and Syncope

ArticleYear
Ventricular tachycardia in a patient with toxoplasmosis.
    British heart journal, 1973, Volume: 35, Issue:3

    Topics: Electrocardiography; Heart Ventricles; Humans; Male; Middle Aged; Myocarditis; Procainamide; Propran

1973